Yaacov Shimon Kagan - 18 Mar 2026 Form 3 Insider Report for ELBIT SYSTEMS LTD (ESLT)

Role
Executive Vice President, CFO
Signature
/s/ Adi Pinchas Confino, Attorney-in-Fact
Issuer symbol
ESLT
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 13:30:39 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kagan Yaacov Shimon Executive Vice President, CFO ADVANCED TECHNOLOGY CENTER PO BOX 539, AT ELBIT SYSTEMS LTD., HAIFA, ISRAEL /s/ Adi Pinchas Confino, Attorney-in-Fact 18 Mar 2026 0002108891

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ESLT Employee Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 12,000 $216.53 Held in an employee benefit trust by IBI Trust Management F1, F2, F3
holding ESLT Employee Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 60,000 $197.82 Held in an employee benefit trust by IBI Trust Management F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Kagan received a grant of options on September 14, 2022, 60% of which has vested and become exercisable. The remaining 40% will vest in two tranches: 20% on September 14, 2026 and 20% on September 14, 2027.
F2 Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Dr. Kagan to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Dr. Kagan following any exercise of options will likely be fewer than the number of shares subject to the options.
F3 Dr. Kagan's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Dr. Kagan is the sole beneficiary of the options.
F4 Dr. Kagan received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney